- Home
- CAPT vs IPSC Comparison
CAPT vs IPSC Comparison
Compare CAPT & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- IPSC
- Stock Information
- Founded
- CAPT 2005
- IPSC 2019
- Country
- CAPT South Korea
- IPSC United States
- Employees
- CAPT N/A
- IPSC N/A
- Industry
- CAPT Blank Checks
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- CAPT Finance
- IPSC Health Care
- Exchange
- CAPT Nasdaq
- IPSC Nasdaq
- Market Cap
- CAPT 41.1M
- IPSC 42.2M
- IPO Year
- CAPT N/A
- IPSC 2021
- Fundamental
- Price
- CAPT $1.05
- IPSC $0.51
- Analyst Decision
- CAPT
- IPSC Strong Buy
- Analyst Count
- CAPT 0
- IPSC 5
- Target Price
- CAPT N/A
- IPSC $3.33
- AVG Volume (30 Days)
- CAPT 161.0K
- IPSC 795.7K
- Earning Date
- CAPT 01-01-0001
- IPSC 08-14-2025
- Dividend Yield
- CAPT N/A
- IPSC N/A
- EPS Growth
- CAPT N/A
- IPSC N/A
- EPS
- CAPT N/A
- IPSC N/A
- Revenue
- CAPT $17,389,944.00
- IPSC $114,128,000.00
- Revenue This Year
- CAPT N/A
- IPSC $1,590.09
- Revenue Next Year
- CAPT N/A
- IPSC N/A
- P/E Ratio
- CAPT N/A
- IPSC N/A
- Revenue Growth
- CAPT 84.70
- IPSC 5491.77
- 52 Week Low
- CAPT $0.37
- IPSC $0.34
- 52 Week High
- CAPT $2.60
- IPSC $2.05
- Technical
- Relative Strength Index (RSI)
- CAPT 39.31
- IPSC 40.42
- Support Level
- CAPT $1.13
- IPSC $0.50
- Resistance Level
- CAPT $1.30
- IPSC $0.59
- Average True Range (ATR)
- CAPT 0.07
- IPSC 0.04
- MACD
- CAPT -0.02
- IPSC -0.00
- Stochastic Oscillator
- CAPT 10.34
- IPSC 28.24
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.